Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Fabbrocini

Showing results (71-80 of 624) with videos related to

Pageof 63
Sort By:
Skin Appendage Disorders|March 1, 2019
It Is Not as It SeemsAlessia Villani, Maria Ferrillo, Gabriella Fabbrocini, et al.
Italian Journal of Dermatology and Venereology|January 17, 2019
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal regionEleonora Cinelli, Maria Vastarella, Gabriella Fabbrocini, et al.
Dermatologic Therapy|April 28, 2020
Biologics for psoriasis in COVID-19 era: What do we know?Matteo Megna, Maddalena Napolitano, Cataldo Patruno, et al.
Dermatology and Therapy|May 30, 2020
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to AdoptAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Facial Plastic Surgery : FPS|December 22, 2009
Chemical peels: what's new and what isn't new but still works wellGabriella Fabbrocini, Maria Pia De Padova, Antonella Tosti
Dermatologic Therapy|November 18, 2020
A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumabCataldo Patruno, Maria Ferrillo, Gabriella Fabbrocini, et al.
Dermatologic Therapy|September 2, 2020
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemicAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of Cosmetic Dermatology|January 22, 2019
15 keto fluprostenol isopropyl ester (80 µgr/mL) gel for cosmetic eyelash growth and enhancementGabriella Fabbrocini, Alessandro Napolitano, Anna Masarà, et al.
International Journal of Dermatology|May 11, 2022
Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral centerFabrizio Martora, Gabriella Fabbrocini, Paola Nappa, et al.
Dermatologic Therapy|June 17, 2021
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?Matteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 63

Showing results (71-80 of 624) with videos related to

Sort By:
Pageof 63
Skin Appendage Disorders|March 1, 2019
It Is Not as It SeemsAlessia Villani, Maria Ferrillo, Gabriella Fabbrocini, et al.
Italian Journal of Dermatology and Venereology|January 17, 2019
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal regionEleonora Cinelli, Maria Vastarella, Gabriella Fabbrocini, et al.
Dermatologic Therapy|April 28, 2020
Biologics for psoriasis in COVID-19 era: What do we know?Matteo Megna, Maddalena Napolitano, Cataldo Patruno, et al.
Dermatology and Therapy|May 30, 2020
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to AdoptAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Facial Plastic Surgery : FPS|December 22, 2009
Chemical peels: what's new and what isn't new but still works wellGabriella Fabbrocini, Maria Pia De Padova, Antonella Tosti
Dermatologic Therapy|November 18, 2020
A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumabCataldo Patruno, Maria Ferrillo, Gabriella Fabbrocini, et al.
Dermatologic Therapy|September 2, 2020
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemicAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of Cosmetic Dermatology|January 22, 2019
15 keto fluprostenol isopropyl ester (80 µgr/mL) gel for cosmetic eyelash growth and enhancementGabriella Fabbrocini, Alessandro Napolitano, Anna Masarà, et al.
International Journal of Dermatology|May 11, 2022
Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral centerFabrizio Martora, Gabriella Fabbrocini, Paola Nappa, et al.
Dermatologic Therapy|June 17, 2021
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?Matteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 63